Texas Yale Capital Corp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $488K | Hold |
8,050
| – | – | 0.01% | 369 |
|
|
2025
Q4 | $434K | Hold |
8,050
| – | – | 0.01% | 381 |
|
|
2025
Q3 | $363K | Hold |
8,050
| – | – | 0.01% | 395 |
|
|
2025
Q2 | $373K | Sell |
8,050
-1,000
| -11% | -$49.1K | 0.01% | 371 |
|
|
2025
Q1 | $552K | Hold |
9,050
| – | – | 0.02% | 322 |
|
|
2024
Q4 | $512K | Hold |
9,050
| – | – | 0.02% | 322 |
|
|
2024
Q3 | $468K | Hold |
9,050
| – | – | 0.02% | 338 |
|
|
2024
Q2 | $376K | Sell |
9,050
-880
| -9% | -$39.4K | 0.02% | 350 |
|
|
2024
Q1 | $539K | Hold |
9,930
| – | – | 0.02% | 316 |
|
|
2023
Q4 | $510K | Sell |
9,930
-3,860
| -28% | -$203K | 0.02% | 316 |
|
|
2023
Q3 | $800K | Sell |
13,790
-130
| -0.9% | -$7.96K | 0.04% | 258 |
|
|
2023
Q2 | $890K | Sell |
13,920
-735
| -5% | -$49.3K | 0.04% | 257 |
|
|
2023
Q1 | $1.02M | Hold |
14,655
| – | – | 0.05% | 241 |
|
|
2022
Q4 | $1.05M | Hold |
14,655
| – | – | 0.06% | 235 |
|
|
2022
Q3 | $1.04M | Sell |
14,655
-366
| -2% | -$26.6K | 0.07% | 225 |
|
|
2022
Q2 | $1.16M | Hold |
15,021
| – | – | 0.07% | 215 |
|
|
2022
Q1 | $1.1M | Buy |
15,021
+765
| +5% | +$51.4K | 0.06% | 233 |
|
|
2021
Q4 | $889K | Buy |
14,256
+35
| +0.2% | +$2.05K | 0.05% | 261 |
|
|
2021
Q3 | $841K | Buy |
14,221
+60
| +0.4% | +$3.95K | 0.05% | 256 |
|
|
2021
Q2 | $946K | Buy |
14,161
+185
| +1% | +$12.1K | 0.05% | 246 |
|
|
2021
Q1 | $882K | Buy |
13,976
+385
| +3% | +$24K | 0.06% | 249 |
|
|
2020
Q4 | $843K | Sell |
13,591
-210
| -2% | -$12.9K | 0.06% | 254 |
|
|
2020
Q3 | $832K | Hold |
13,801
| – | – | 0.06% | 242 |
|
|
2020
Q2 | $811K | Buy |
13,801
+3,040
| +28% | +$182K | 0.07% | 235 |
|
|
2020
Q1 | $600K | Sell |
10,761
-2,525
| -19% | -$154K | 0.06% | 258 |
|
|
2019
Q4 | $853K | Buy |
13,286
+1,346
| +11% | +$77.1K | 0.06% | 267 |
|
|
2019
Q3 | $605K | Hold |
11,940
| – | – | 0.04% | 299 |
|
|
2019
Q2 | $541K | Sell |
11,940
-11,940
| -50% | -$556K | 0.04% | 321 |
|
|
2019
Q1 | $1.14M | Buy |
23,880
+11,940
| +100% | +$595K | 0.05% | 303 |
|
|
2018
Q4 | $621K | Sell |
11,940
-122
| -1% | -$6.55K | 0.06% | 268 |
|
|
2018
Q3 | $749K | Hold |
12,062
| – | – | 0.06% | 268 |
|
|
2018
Q2 | $668K | Sell |
12,062
-2,825
| -19% | -$153K | 0.06% | 274 |
|
|
2018
Q1 | $942K | Sell |
14,887
-860
| -5% | -$55.3K | 0.08% | 226 |
|
|
2017
Q4 | $965K | Buy |
15,747
+122
| +0.8% | +$7.63K | 0.08% | 229 |
|
|
2017
Q3 | $996K | Hold |
15,625
| – | – | 0.09% | 220 |
|
|
2017
Q2 | $871K | Hold |
15,625
| – | – | 0.08% | 236 |
|
|
2017
Q1 | $850K | Sell |
15,625
-850
| -5% | -$46.6K | 0.07% | 236 |
|
|
2016
Q4 | $963K | Sell |
16,475
-375
| -2% | -$20.5K | 0.09% | 197 |
|
|
2016
Q3 | $909K | Sell |
16,850
-1,225
| -7% | -$78.7K | 0.09% | 208 |
|
|
2016
Q2 | $1.33M | Sell |
18,075
-80
| -0.4% | -$5.65K | 0.13% | 141 |
|
|
2016
Q1 | $1.16M | Sell |
18,155
-1,800
| -9% | -$114K | 0.12% | 152 |
|
|
2015
Q4 | $1.37M | Sell |
19,955
-1,075
| -5% | -$71K | 0.13% | 126 |
|
|
2015
Q3 | $1.25M | Sell |
21,030
-540
| -3% | -$34.3K | 0.12% | 149 |
|
|
2015
Q2 | $1.44M | Hold |
21,570
| – | – | 0.12% | 148 |
|
|
2015
Q1 | $1.39M | Sell |
21,570
-2,130
| -9% | -$133K | 0.11% | 153 |
|
|
2014
Q4 | $1.4M | Buy |
23,700
+185
| +0.8% | +$10.4K | 0.12% | 135 |
|
|
2014
Q3 | $1.2M | Buy |
23,515
+955
| +4% | +$47.7K | 0.11% | 134 |
|
|
2014
Q2 | $1.09M | Buy |
22,560
+2,640
| +13% | +$130K | 0.14% | 139 |
|
|
2014
Q1 | $1.03M | Buy |
19,920
+3,545
| +22% | +$189K | 0.14% | 131 |
|
|
2013
Q4 | $870K | Buy |
16,375
+200
| +1% | +$10.2K | 0.13% | 133 |
|
|
2013
Q3 | $749K | Buy |
16,175
+875
| +6% | +$38.4K | 0.13% | 144 |
|
|
2013
Q2 | $684K | Buy |
+15,300
| New | +$664K | 0.12% | 148 |
|
Other funds holding BMY
VCM
VPM
Texas Yale Capital Corp's BMY Position: Q1 2026 in Review
Texas Yale Capital Corp held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 8,050 shares worth $488K. The position accounts for 0.01% of the portfolio, ranked #369.
Texas Yale Capital Corp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.44M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Texas Yale Capital Corp held 8,050 shares of Bristol-Myers Squibb worth $488K as of Q1 2026.
- Texas Yale Capital Corp left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.01% of Texas Yale Capital Corp's portfolio in Q1 2026, its #369 holding.
- Texas Yale Capital Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Texas Yale Capital Corp's Bristol-Myers Squibb position peaked at $1.44M in Q2 2015.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Texas Yale Capital Corp's 13F filing for Q1 2026, filed 4 May 2026.